attia glp 1 246 - AMA #45: Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent Neurobiological Mechanisms and Therapeutic Potential

Summary GLP-1 RAs offer a multifaceted therapeutic strategy in PD, targeting both central neurodegenerative processes and peripheral metabolic dysfunction

GLP-1 medications offer metabolic benefits for many patients, but specific contraindications and risk factors determine who should not use them

The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes

But whats clear is this: midlife women arent single-variable systems

20122014 Expanded Therapeutic Options The approvals of Qsymia, Belviq, Contrave, and Saxenda broadened the treatment landscape and reinforced obesity as a chronic disease requiring evidence-based medical management